SK278546B6 - Pharmaceutical composition for healing autoimmune deseases - Google Patents
Pharmaceutical composition for healing autoimmune deseases Download PDFInfo
- Publication number
- SK278546B6 SK278546B6 SK1227-92A SK122792A SK278546B6 SK 278546 B6 SK278546 B6 SK 278546B6 SK 122792 A SK122792 A SK 122792A SK 278546 B6 SK278546 B6 SK 278546B6
- Authority
- SK
- Slovakia
- Prior art keywords
- compound
- pharmaceutical composition
- formula
- autoimmune diseases
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Reproductive Health (AREA)
- Rheumatology (AREA)
- Urology & Nephrology (AREA)
- Transplantation (AREA)
- Endocrinology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Steroid Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ITMI911101A IT1253703B (it) | 1991-04-22 | 1991-04-22 | Uso di acidi metossi alcanoici dell'indazolo per preparare un farmaco attivo nel trattamento di malattie autoimmunitarie |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SK278546B6 true SK278546B6 (en) | 1997-09-10 |
Family
ID=11359721
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SK1227-92A SK278546B6 (en) | 1991-04-22 | 1992-04-22 | Pharmaceutical composition for healing autoimmune deseases |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US5278183A (da) |
| EP (1) | EP0510748B1 (da) |
| JP (1) | JP3056879B2 (da) |
| KR (1) | KR100210199B1 (da) |
| AT (1) | ATE135573T1 (da) |
| AU (1) | AU657524B2 (da) |
| BG (1) | BG61366B2 (da) |
| CA (1) | CA2066304C (da) |
| CZ (1) | CZ280613B6 (da) |
| DE (1) | DE69209128T2 (da) |
| DK (1) | DK0510748T3 (da) |
| IL (1) | IL101660A (da) |
| IT (1) | IT1253703B (da) |
| NZ (1) | NZ242392A (da) |
| SK (1) | SK278546B6 (da) |
| ZA (1) | ZA922740B (da) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2723315B1 (fr) * | 1994-08-02 | 1996-10-25 | Cird Galderma | Procede et composition pour stimuler la differenciation des cellules preadipocytaires et traitements therapeutiques associes |
| IT1276031B1 (it) * | 1995-10-31 | 1997-10-24 | Angelini Ricerche Spa | Composizione farmaceutica per il trattamento delle malattie autoimmuni |
| IT1293795B1 (it) * | 1997-07-28 | 1999-03-10 | Angelini Ricerche Spa | Farmaco attivo nel ridurre la produzione di proteina mcp-1 |
| JP2005510492A (ja) * | 2001-10-26 | 2005-04-21 | ユニバーシティ オブ コネチカット | 新規な種類の効力のあるカンナビミメティックリガンド |
| ITMI20062254A1 (it) * | 2006-11-24 | 2008-05-25 | Acraf | Uso di un acido metossi-alcanoico dell'indazolo per preparare una composizione farmaceutca |
| AU2009221087B2 (en) | 2008-03-07 | 2013-12-05 | Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.P.A. | 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of MCP-1, CX3CR1 and p40 |
| DK2262777T3 (da) | 2008-03-07 | 2016-05-17 | Acraf | 1-benzyl-3-hydroxymetylindazolderivater og anvendelse deraf ved behandling af sygdomme baseret på eksprimering af MCP-1 og CX3CR1 |
| JP5509101B2 (ja) * | 2008-03-07 | 2014-06-04 | アジェンデ・キミケ・リウニテ・アンジェリニ・フランチェスコ・ア・チ・エレ・ア・エフェ・ソシエタ・ペル・アチオニ | 新規な１−ベンジル−３−ヒドロキシメチルインダゾール誘導体、ならびにそのＭＣＰ−１、ＣＸ３ＣＲ１およびｐ４０の発現に基づく疾患の治療への使用 |
| MX2012001520A (es) | 2009-08-03 | 2012-06-01 | Acraf | Proceso para la preparacion de 1-bencil-3-hidroximetil-1h-indazol y sus derivados e intermediarios de magnesio requeridos. |
| UA108742C2 (uk) * | 2009-09-23 | 2015-06-10 | Фармацевтична композиція для лікування запальних захворювань, опосередкованих mcp-1 | |
| US8999292B2 (en) | 2012-05-01 | 2015-04-07 | Translatum Medicus Inc. | Methods for treating and diagnosing blinding eye diseases |
| CA3144861A1 (en) | 2019-06-25 | 2020-12-30 | Translatum Medicus, Inc. | Processes of making 2-((1-benzyl-1h-indazol-3-yl)methoxy)-2-methylpropanoic acid and its derivatives |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1194564B (it) * | 1983-04-18 | 1988-09-22 | Acraf | Impiego del bendazac e dei suoi sali nel trattamento della retinite pigmentosa |
| EP0191520B1 (en) * | 1985-02-12 | 1989-06-21 | AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO A.C.R.A.F. S.p.A. | (1-phenylmethyl-5-hydroxy-1h-indazol-3-yl)-oxyacetic acid and salts thereof for use as a medicament, and pharmaceutical compositions containing them |
| IT1230441B (it) * | 1989-02-07 | 1991-10-23 | Acraf | Eteri della serie dell'indazolo |
-
1991
- 1991-04-22 IT ITMI911101A patent/IT1253703B/it active IP Right Grant
-
1992
- 1992-04-11 DE DE69209128T patent/DE69209128T2/de not_active Expired - Lifetime
- 1992-04-11 AT AT92201037T patent/ATE135573T1/de active
- 1992-04-11 DK DK92201037.6T patent/DK0510748T3/da active
- 1992-04-11 EP EP92201037A patent/EP0510748B1/en not_active Expired - Lifetime
- 1992-04-14 AU AU14883/92A patent/AU657524B2/en not_active Expired
- 1992-04-14 US US07/868,311 patent/US5278183A/en not_active Expired - Lifetime
- 1992-04-14 ZA ZA922740A patent/ZA922740B/xx unknown
- 1992-04-16 CA CA002066304A patent/CA2066304C/en not_active Expired - Lifetime
- 1992-04-16 NZ NZ242392A patent/NZ242392A/en not_active IP Right Cessation
- 1992-04-21 IL IL10166092A patent/IL101660A/en not_active IP Right Cessation
- 1992-04-22 SK SK1227-92A patent/SK278546B6/sk not_active IP Right Cessation
- 1992-04-22 CZ CS921227A patent/CZ280613B6/cs not_active IP Right Cessation
- 1992-04-22 KR KR1019920006797A patent/KR100210199B1/ko not_active IP Right Cessation
- 1992-04-22 JP JP4102849A patent/JP3056879B2/ja not_active Expired - Lifetime
-
1994
- 1994-02-25 BG BG98590A patent/BG61366B2/bg unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU1488392A (en) | 1992-10-29 |
| KR100210199B1 (ko) | 1999-07-15 |
| DE69209128D1 (de) | 1996-04-25 |
| ZA922740B (en) | 1992-12-30 |
| JPH0640915A (ja) | 1994-02-15 |
| AU657524B2 (en) | 1995-03-16 |
| CZ280613B6 (cs) | 1996-03-13 |
| ATE135573T1 (de) | 1996-04-15 |
| EP0510748A1 (en) | 1992-10-28 |
| DE69209128T2 (de) | 1996-11-28 |
| KR920019350A (ko) | 1992-11-19 |
| BG61366B2 (bg) | 1997-06-30 |
| NZ242392A (en) | 1997-06-24 |
| ITMI911101A0 (it) | 1991-04-22 |
| CA2066304A1 (en) | 1992-10-23 |
| CA2066304C (en) | 2005-06-21 |
| DK0510748T3 (da) | 1996-07-22 |
| US5278183A (en) | 1994-01-11 |
| IT1253703B (it) | 1995-08-23 |
| EP0510748B1 (en) | 1996-03-20 |
| JP3056879B2 (ja) | 2000-06-26 |
| ITMI911101A1 (it) | 1992-10-22 |
| IL101660A (en) | 1996-08-04 |
| CS122792A3 (en) | 1992-11-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SK278546B6 (en) | Pharmaceutical composition for healing autoimmune deseases | |
| Adeyeye et al. | Diclofenac sodium | |
| Ham et al. | Studies on the mode of action of non-steroidal anti-inflammatory agents | |
| Green | The anti-inflammatory effect of catecholamines in the peritoneal cavity and hind paw of the mouse | |
| BRPI0615046A2 (pt) | uso de um composto, e, formulação para administração oral | |
| US20100222376A1 (en) | Chelerythrine, analogs thereof and their use in the treatment of bipolar disorder and other cognitive disorders | |
| PT688215E (pt) | 3,4-diarilcromanos para o tratamento de dermatite | |
| JPH07504915A (ja) | ムスカリン拮抗物質投与による，哺乳動物の眼における眼内圧低下法 | |
| Filderman et al. | Anti-inflammatory activity of the steroid alkaloid glycoside, tomatine | |
| CA1228818A (en) | Treatment of seizure disorders and pharmaceutical compositions useful therein | |
| US5475033A (en) | Anti-allergic pharmaceutical composition for ophthalmic topical administration | |
| US3157655A (en) | Pyrazolopyrimidine derivative | |
| Megel et al. | The anti-inflammatory actions of tilorone hydrochloride | |
| YAMADA et al. | Gastric acidity-dependent bioavailability of commercial sustained release preparations of indomethacin, evaluated by gastric acidity-controlled beagle dogs | |
| JPH06329538A (ja) | 皮膚疾患処置用薬剤 | |
| Ellis et al. | Dibenamine blockade of epinephrine and glucagon hyperkalemias. | |
| Mulqueen et al. | Oral, anti-inflammatory activity of a potent, selective, protein kinase C inhibitor | |
| JPS6263520A (ja) | 抗リウマチ剤 | |
| US20060287353A1 (en) | Method for preventing or treating ischemia-or hemorrhage-induced brain damage using a macrolide compound | |
| HU219406B (hu) | Eljárás autoimmun betegségek kezelésére alkalmas, benzil-indazol-származékokat tartalmazó gyógyszerkészítmények előállítására | |
| RU2160102C2 (ru) | Применение бензидамина для лечения патологических состояний, вызванных фно | |
| Kabara | Brain cholesterol XVIII: EFFECt of methylphenidate (Ritalin) on [U-14C] glucose and [2-3H] acetate incorporation | |
| Gardey-Levassort et al. | Action of Probenecid on the Central Nervous System of the Rabbit: I. Effects on the Elimination of 5-Hydroxyindoleacetic Acid | |
| Roberts et al. | Effect of H2-receptor antagonists on steady-state extraction of indocyanine green and lidocaine by the perfused rat liver | |
| CA1296639C (en) | Agent for treatment of kidney diseases |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK4A | Patent expired |
Expiry date: 20120422 |